期刊文献+

冠状动脉痉挛临床研究进展 被引量:4

下载PDF
导出
出处 《广东医学》 CAS CSCD 北大核心 2009年第12期1769-1771,共3页 Guangdong Medical Journal
  • 相关文献

参考文献28

  • 1YASUE H, SASAYAMA S, KIKUCHI K, et al. The study on the role of coronary spasm in ischemic heart disease. In : Annual report of the research on cardiovascular diseases [ M ]. Osaka : National Cardiovascular Center, 2000: 96- 97.
  • 2ONG P, ATHANASIADIS A, HILL S, et al. Coronary artery spasm as a frequent cause of acute coronary syndrome: The CASPAR (Coronary Artery Spasm in Patients With Acute Coronary Syndrome) Study[J]. J Am Coil Cardiol, 2008, 52(7) : 523 -527.
  • 3PRISTIPINO C, BELTRAME J F, FINOCCHIARO M L, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction[J]. Circulation, 2000, 101(10) : 1102 -1108.
  • 4YASUE H, NAKAGAWA H, ITOH T, et al. Coronary artery spasm-clinical features, diagnosis, pathogenesis, and treatment [J]. J Cardiol, 2008, 51(1): 2-17.
  • 5KUGIYAMA K, YASUE H, OKUMURA K, et al. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina[J].Circulation, 1996, 94 (3) : 266 - 271.
  • 6关启刚,曾定尹,孙喜琢,苗志林,周旭晨,何学志,韩凤桐,程颖,张利.Rho激酶在小型猪白介素-1β介导的冠状动脉痉挛中的作用机制[J].中华心血管病杂志,2006,34(1):50-53. 被引量:19
  • 7SHIMOKAWA H, TAKESHITA A. Rho - kinase is an important therapeutic target in cardiovascular medicine [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25(9): 1767- 1775.
  • 8MASUMOTO A, MOHRI M, SHIMOKAWA H, et al. Suppression of coronary artery spasm by the Rho - kinase inhibitor fasudil in patients with vasospastic angina [ J ]. Circulation, 2002, 105 (13) : 1545 - 1547.
  • 9MURAD F. Nitric oxide and cyclic GMP in cell signaling and drug development [ J ]. N Engl J Med, 2006, 355 (19) : 2003 - 2011.
  • 10KUGIYAMA K, MIYAO Y, SAKAMOTO T, et al. Glutathione attenuates coronary constriction to acetylcholine in patients with coronary spastic angina [ J ]. Am J Physiol Heart Circ Physiol, 2001, 280( 1 ) : H264 - H271.

二级参考文献19

  • 1Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. J Cardiovasc Pharmacol, 2002,39 : 319-327.
  • 2Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med,1999,340:115-126.
  • 3Li JJ. Silent myocardial isehemia may be related to inflammatory response. Med Hypotheses,2004,62:252-256.
  • 4Shimokawa H, Ito A, Fukumoto Y, et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor.J Clin Invest, 1996.97:769-776.
  • 5Kolodgie FD, Virmani B, Cornhill JF, et al. Increase in atherosclerosis and adventitial mast cells in cocaine abusers: an alternative mechanism of cocaine-associated coronary vasospasm and thrombosis. J Am Coll Cardiol, 1991,17 : 1553 -1560.
  • 6Bhagat K, Vallance p. Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation, 1997,96:3042-3047.
  • 7Robinson LI, Busconi L, Michel T. Agonlst-modulaled palmitoylatlon of endothelial nitric oxide synthase. J Biol Chem,1995,270:995-998.
  • 8Matsui T,Amano M,Yamamoto T, et at. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J, 1996,15:2208-2216.
  • 9Shimokawa H. Cellular and molecular mechanisms of coronary artery spasm: lessons from animal models. Jpn Circ J,2000,64:1-12.
  • 10Somlyo AV. New roads leading to Ca2 + sensitization. Cite Res,2002,91:83-84.

共引文献21

同被引文献40

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部